Kintara Therapeutics Stock to Reverse Split on Friday, October 18th (NASDAQ:KTRA)

Kintara Therapeutics, Inc. (NASDAQ:KTRA)’s stock is set to reverse split before the market opens on Friday, October 18th. The 1-35 reverse split was announced on Monday, October 14th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, October 17th.

Kintara Therapeutics Price Performance

KTRA stock opened at $0.23 on Wednesday. The company has a 50 day moving average price of $0.19 and a 200 day moving average price of $0.20. Kintara Therapeutics has a fifty-two week low of $0.08 and a fifty-two week high of $4.59. The stock has a market capitalization of $12.55 million, a PE ratio of -0.06 and a beta of 0.82.

About Kintara Therapeutics

Kintara Therapeutics, Inc, a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients.